Your browser doesn't support javascript.
loading
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura, Tomokazu; Ito, Jumpei; Uriu, Keiya; Zahradnik, Jiri; Kida, Izumi; Anraku, Yuki; Nasser, Hesham; Shofa, Maya; Oda, Yoshitaka; Lytras, Spyros; Nao, Naganori; Itakura, Yukari; Deguchi, Sayaka; Suzuki, Rigel; Wang, Lei; Begum, Mst Monira; Kita, Shunsuke; Yajima, Hisano; Sasaki, Jiei; Sasaki-Tabata, Kaori; Shimizu, Ryo; Tsuda, Masumi; Kosugi, Yusuke; Fujita, Shigeru; Pan, Lin; Sauter, Daniel; Yoshimatsu, Kumiko; Suzuki, Saori; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Yamamoto, Yuki; Nagamoto, Tetsuharu; Schreiber, Gideon; Maenaka, Katsumi; Hashiguchi, Takao; Ikeda, Terumasa; Fukuhara, Takasuke; Saito, Akatsuki; Tanaka, Shinya; Matsuno, Keita; Takayama, Kazuo; Sato, Kei.
Affiliation
  • Tamura T; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Ito J; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Uriu K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Zahradnik J; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kida I; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Anraku Y; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Nasser H; First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia.
  • Shofa M; Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Oda Y; Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Lytras S; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.
  • Nao N; Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  • Itakura Y; Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan.
  • Deguchi S; Graduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan.
  • Suzuki R; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Wang L; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Begum MM; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Kita S; One Health Research Center, Hokkaido University, Sapporo, Japan.
  • Yajima H; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Sasaki J; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Sasaki-Tabata K; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Shimizu R; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Tsuda M; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Kosugi Y; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Fujita S; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Pan L; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.
  • Sauter D; Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Yoshimatsu K; Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Suzuki S; Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Asakura H; Department of Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Nagashima M; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.
  • Sadamasu K; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Yoshimura K; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Yamamoto Y; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nagamoto T; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Schreiber G; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Maenaka K; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hashiguchi T; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
  • Ikeda T; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Fukuhara T; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
  • Saito A; Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
  • Tanaka S; Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Matsuno K; Institute for Vaccine Research and Development, HU-IVReD, Hokkaido University, Sapporo, Japan.
  • Takayama K; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Sato K; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Nat Commun ; 14(1): 2800, 2023 05 16.
Article de En | MEDLINE | ID: mdl-37193706
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Animals / Humans / Male Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Animals / Humans / Male Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni